South Korea passed a revised foreign-patient law on May 26 that legalizes telemedicine for international patients, allowing licensed doctors at designated institutions to run digital consultations, remote monitoring, diagnoses and prescriptions across borders. Notably, it permits remote first-time appointments for overseas patients, something still banned for domestic patients under the country's Medical Service Act. The framework takes effect in 2027 after a 12-month grace period, with a government-built international telemedicine platform and secure prescription systems planned.

The aesthetics angle is in the numbers. South Korea drew 2.01 million international patients in the prior year, with dermatology and plastic surgery together making up roughly three-quarters of visits. Opening legal remote intake for that traffic is a deliberate move to make Korea the front door for cross-border cosmetic care, from pre-treatment consults to follow-up.

For US clinics this is not an immediate operational change, but it is a signal of where medical-tourism competition is heading. If patients start arriving having already done a remote Seoul consult, knowing how that pathway works is worth tracking.

Source: The Korea Times — https://www.koreatimes.co.kr/southkorea/health/20260526/korea-legalizes-telemedicine-for-foreign-patients-to-boost-medical-tourism